QLGN News and Press, Qualigen Therapeutics Inc. From 08/14/20

Qualigen Therapeutics (NASDAQ: QLGN ) : FQ1 GAAP EPS of -$2.12. More news on: Qualigen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CARLSBAD, Calif. , Aug. 14, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) today announced business highlights and financial results for the fiscal year 2021 first quarter, ended June 30, 2020 . Business highlights for the fiscal first...

Volatility watch: Some of the volatility names to watch include Colony Capital (NYSE: CLNY ) , American Eagle Outfitters (NYSE: AEO ) and Brookfield Property Partners (NASDAQ: BPY ) with short interest positions on the rise. Virgin Galactic (NYSE: SPCE ) and National Beverage (NAS...

CARLSBAD, Calif. , Aug. 6, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that it will host a business update conference call and live webcast on Tuesday, August 18, 2020 at 4:30 p.m. Eastern time . During the call,...

CARLSBAD, Calif. , Aug. 4, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional in...

Qualigen Therapeutics (NASDAQ: QLGN ) inks agreement with an institutional investor for the purchase and sale for $10M of (i) 1,717,106 common shares and (ii) 1,287,829 common warrants at a combined purchase price of $5.82375 ($5.73/share and $0.125/warrant) in a registered direct o...

CARLSBAD, Calif. , Aug. 2, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 Commo...